35 Results for "

Hsp90β

" in MedChemExpress (MCE) Product Catalog:
Products (35)

35 Results for "Hsp90β" in MCE Product Catalog:

26
26 Publications Verification
Cat. No.: HY-10215
CAS No.: 747412-49-3
Purity:  99.74%
Synonyms: VER-52296; AUY922; NVP-AUY922
Target:  

HSP Autophagy Apoptosis

Research Areas:  

Cancer

Luminespib (VER-52296) is a potent HSP90 inhibitor with IC50s of 7.8 and 21 nM for HSP90α and HSP90β, respectively .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-15785
CAS No.: 1260533-36-5
Purity:  98.79%
Synonyms: TAS-116
Target:  

HSP

Research Areas:  

Cancer

Pimitespib (TAS-116) is an oral bioavailable, ATP-competitive, highly specific HSP90α/HSP90β inhibitor (Kis of 34.7 nM and 21.3 nM, respectively) without inhibiting other HSP90 family proteins such as GRP94 . Pimitespib demonstrates less ocular toxicity .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-13469
CAS No.: 1061318-81-7
Purity:  99.82%
Synonyms: CUDC-305
Target:  

HSP

Research Areas:  

Cancer

Debio 0932 (CUDC-305) is an orally active HSP90 inhibitor, with IC50s of 100 and 103 nM for HSP90α and HSP90β, respectively .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10942
CAS No.: 847559-80-2
Purity:  98.76%
Synonyms: NVP-BEP800
Target:  

HSP

Research Areas:  

Cancer

VER-82576 (NVP-BEP800) is a potent, orally available and selective Hsp90 inhibitor, with an IC50 of 58 nM for Hsp90β; VER-82576 also slightly blocks Grp94 and Trap-1, with IC50s of 4.1 and 5.5 μM, respectively.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15190
CAS No.: 934343-74-5
Purity:  99.49%
Synonyms: Hsp-990
Target:  

HSP Apoptosis

Research Areas:  

Cancer

NVP-HSP990 is a potent, selective and orally active Hsp90 inhibitor, with IC50 values of 0.6, 0.8, and 8.5 nM for Hsp90α, Hsp90β, and Grp94, respectively.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10214
CAS No.: 908112-43-6
Purity:  99.49%
Synonyms: PF-04928473
Target:  

HSP Autophagy

Research Areas:  

Cancer

SNX-2112 (PF 04928473) is an orally active Hsp90 inhibitor, with a Kd of 16 nM for Hsp90 and IC50s of 30 nM, 30 nM for Hsp90 α and Hsp90 β, also induces Her-2 degradation, and inhibits Grp94 and Trap-1, with IC50s of 10 nM, 4.275 μM and 0.862 μM, respectively . SNX-2112 (PF 04928473) binds Hsp90 isoforms Hsp90α, Hsp90β and Hsp90b1/Grp94 with Kds of 4 nM, 6 nM and 484 nM, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1434
CAS No.: 957-68-6
Synonyms: 7-ACA
7-aminocephalosporanic acid (7-ACA) is a HSP90β inhibitor and an antibiotic. 7-Aminocephalosporanic acid is the core chemical structure of the synthesis of cephalosporin antibiotics and an effective β-lactamase inhibitor .
loading...
    loading...
Cat. No.: HY-110042
CAS No.: 171009-07-7
Purity:  99.94%
CCT018159 is an ATP-competitive HSP90β inhibitor, with an IC50 of 3.2 μM against human HSP90β ATPase and 6.6 μM against yeast HSP90β ATPase. CCT018159 induces cell cycle arrest and apoptosis in tumor cells, and inhibits invasion and angiogenesis. CCT018159 is applicable to cancer-related research .
loading...
    loading...
Cat. No.: HY-123035
CAS No.: 877773-32-5
Purity:  99.44%
Target:  

HSP Akt EGFR

Research Areas:  

Endocrinology

Gamendazole, an indazole carboxylic acid (ICA), is an orally active, selective HSP90AB1 (HSP90BETA) and EEF1A1 (eEF1A) inhibitor. Gamendazole binds to the C-terminal nucleotide binding pocket of HSP90 and cause downregulation of clients AKT1 and ERBB2, but stabilizes the HSP90 heterocomplex. Gamendazole specifically inhibits the actin bundling function of EEF1A1, but does not bind to the nucleotide docking pocket nor inhibits the ribosome charging or protein translation functions of EEF1A1. Gamendazole, an antispermatogenic compound with antifertility effects, has the potential for reversible non-hormonal male contraceptive agent research .
loading...
    loading...
Cat. No.: HY-P11185
CAS No.: 1141872-74-3
Target:  

HSP

Research Areas:  

Cancer

Hsp90β decapeptide is a C-terminal peptide of Hsp90β, which contains conserved TPR-domain MEEVD. Hsp90β decapeptide is able to bind tightly the Tah1 protein with a Kd of 1.0 μM .
loading...
    loading...
Cat. No.: HY-117395
CAS No.: 1454619-13-6
Purity:  99.04%
Target:  

HSP

Research Areas:  

Cancer

PU-H54, a Grp94-selective inhibitor, can be used for the research of breast cancer. Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90α, Hsp90β, Grp94 and Trap-1, has important roles in malignancy . PU-H54 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-155113
CAS No.: 3031078-90-4
Target:  

PROTACs HSP

Research Areas:  

Cancer

PROTAC Hsp90α degrader 1 is a selective PROTAC Hsp90α degrader with a DC50 of 0.295 μM. PROTAC Hsp90α degrader 1 exhibits antitumor activity with low toxic side effects. PROTAC Hsp90α degrader 1 can be used for the research of breast cancer .
loading...
    loading...
Cat. No.: HY-175008
Target:  

HSP

Research Areas:  

Others

Hsp90β-IN-1 (Compound 7b) is a selective biotinylated inhibitor of heat shock protein 90β (HSP90β) with an IC50 = 0.33 μM .
loading...
    loading...
Cat. No.: HY-178957
Target:  

HSP

Research Areas:  

Cancer

Hsp90β-IN-2 (Compound 16B) is a selective Hsp90β inhibitor with KDs of 225 nM and 73.32 μM against Hsp90β and Hsp90α. KUNB106 exhibits antiproliferative activity against MDA-MB-231 cells, A549 and SKOV-3 cells. KUNB106 can be used for the study of triple negative breast cancer .
loading...
    loading...
Cat. No.: HY-178956
CAS No.: 2393980-27-1
Target:  

HSP

Research Areas:  

Cancer

KUNB106 is a selective Hsp90β inhibitor with KDs of 91 nM and 38 μM against Hsp90β and Hsp90α. KUNB106 exhibits antiproliferative activity against MDA-MB-231 cells, A549 and SKOV-3 cells. KUNB106 can be used for the study of triple negative breast cancer .
loading...
    loading...
Cat. No.: HY-168205
Target:  

HSP Apoptosis

Research Areas:  

Cancer

HSP90-IN-33 (compound 24e) is a potent Hsp90 inhibitor with Kd values of ≥200, 7.3 µM for Hsp90α, Hsp90β, respectively. HSP90-IN-33 induces apoptosis and cell cycle arrest at G0/G1 phase. HSP90-IN-33 decreases the protein expression of ERα, CDK4 and Akt .
loading...
    loading...
Cat. No.: HY-10215R
CAS No.: 747412-49-3
Synonyms: VER-52296 (Standard); AUY922 (Standard); NVP-AUY922 (Standard)
Research Areas:  

Cancer

Luminespib (Standard) is the analytical standard of Luminespib. This product is intended for research and analytical applications. Luminespib (VER-52296) is a potent HSP90 inhibitor with IC50s of 7.8 and 21 nM for HSP90α and HSP90β, respectively .
loading...
    loading...
Cat. No.: HY-B1434R
CAS No.: 957-68-6
Synonyms: 7-ACA (Standard)
7-Aminocephalosporanic acid (Standard) is the analytical standard of 7-Aminocephalosporanic acid. This product is intended for research and analytical applications. 7-aminocephalosporanic acid (7-ACA) is a HSP90β inhibitor and an antibiotic. 7-Aminocephalosporanic acid is the core chemical structure of the synthesis of cephalosporin antibiotics and an effective β-lactamase inhibitor .
loading...
    loading...
Cat. No.: HY-116053
CAS No.: 1454619-18-1
Target:  

HSP

Research Areas:  

Neurological Disease

PU-11 is a Hsp90α/Hsp90β inhibitor with IC50 values of 18.6 μM and 89.8 μM and Kd values of 2 and 4.2 μM. PU-11 binds to the ATP-binding pocket of Hsp90α and Hsp90β and displays selective binding preference for Hsp90α over Hsp90β, mediated by the nonconserved Hsp90α Ser52 residue. PU-11 can be used for the research of neurodegenerative disorders .
loading...
    loading...
Cat. No.: HY-162751
Target:  

HSP Apoptosis

Research Areas:  

Cancer

Anticancer agent 249 (Compound 89) is an inhibitor for Hsp90β with IC50 of 16.5 μM in PC3MM2 cell. Anticancer agent 249 inhibits proliferation of cancer cells MCF-7, T47D, MDA-MB-231, MDA-MB-468 and SKBr3 with IC50 of 1.8-5.3 μM. Anticancer agent 249 induces apoptosis in MDA-MB-231. Anticancer agent 249 exhibits antitumor efficacy in mice .
loading...
    loading...